Oct 24 2019 |
Beef Buyer Class Action Says ‘Big Beef’ Colluded to Score Record Profits by Manipulating Capacity |
MoginRubin |
Oct 24 2019 |
Manufacturers are Not Immune to Claims that their Inventions are Patent-Ineligible |
Robinson & Cole LLP |
Oct 24 2019 |
States Await USDA Hemp Regulations |
Keller and Heckman LLP |
Oct 24 2019 |
Cannabis Coming to the Northeast? Governors of NY, NJ, CT and PA adopt “core principles” to implement adult-use legislation. |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Oct 24 2019 |
Focus On Innovation Centers: Due Diligence For Collaborative Ventures |
McDermott Will & Schulte LLP |
Oct 23 2019 |
National Safety Council States That “No Level of Cannabis Use Is Safe Or Acceptable” For Safety-Sensitive Positions |
Jackson Lewis P.C. |
Oct 23 2019 |
FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD |
Keller and Heckman LLP |
Oct 22 2019 |
Top International News in Chemical Policy and Regulation - October 22, 2019 |
Bergeson & Campbell, P.C. |
Oct 22 2019 |
Vape Lung Disease Chills Cannabis Industry |
Stark & Stark |
Oct 22 2019 |
Opioid Update: Bellwether Settlement on Eve of Trial |
Squire Patton Boggs (US) LLP |
Oct 22 2019 |
New York Court Compels Arbitration of Commercial Marijuana Dispute |
Carlton Fields |
Oct 22 2019 |
USPTO October 2019 Patent Eligibility Guidance Update Includes New Guidance And Examples For Life Sciences |
Foley & Lardner LLP |
Oct 21 2019 |
Federal Appeals Court Holds Test For Illegal Drugs Is Not An Impermissible Medical Examination, Even If Test May Reveal Lawful Drug Use |
Jackson Lewis P.C. |
Oct 21 2019 |
PTO Releases New Guidelines on Subject Matter Eligibility |
Schwegman, Lundberg & Woessner, P.A. |
Oct 21 2019 |
Lawmaker Calls for FDA to Respond to Report on Toxic Metals in Baby Food |
Keller and Heckman LLP |
Oct 21 2019 |
FDA Warns Consumers to Stop Using THC Vaping Products Amid Ongoing Investigation into Lung Injuries |
Dinsmore & Shohl LLP |
Oct 18 2019 |
BRAG Biobased Products Blog: October 18, 2019 |
Bergeson & Campbell, P.C. |
Oct 18 2019 |
USDA Announces Renewal of Substance Exemptions in the National Organic Program |
Keller and Heckman LLP |
Oct 17 2019 |
Mexico’s Lower House Passes Front-of-Pack Labeling Bill |
Keller and Heckman LLP |
Oct 17 2019 |
California Tackles Big Pharma’s Anticompetitive ‘Pay for Delay’ Practices That Slow Down Lower-Cost Generic Drug Development |
MoginRubin |
Oct 16 2019 |
Personalized Cancer Therapy Found Nonobvious |
Foley & Lardner LLP |
Oct 16 2019 |
Pork Workers Union Sues USDA Over New Swine Slaughter Inspection System |
Keller and Heckman LLP |
Oct 15 2019 |
Not Another Puff Piece: The Difference Between Puffery and False Advertising |
ArentFox Schiff LLP |
Oct 15 2019 |
EPA OIG Will Evaluate Implementation of 2009 TSCA PMN Consent Order with DuPont [Chemours] |
Bergeson & Campbell, P.C. |
Oct 15 2019 |
Federal Circuit Reverses PTAB Finding Tarceva® Method of Treatment Claims Invalid for Lack of Reasonable Expectation of Success Based on over 99.5% Failure Rate among Treatment Candidates |
Mintz |
Oct 15 2019 |
Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent |
Foley & Lardner LLP |
Oct 15 2019 |
Suit Over ‘No Preservatives’ Capri Sun Label Tossed |
Keller and Heckman LLP |
Oct 15 2019 |
FTC Ratchets up Scrutiny on Pharmaceutical Deals |
McDermott Will & Schulte LLP |
Oct 11 2019 |
Text Message Platform Dismissed From TCPA Class Action Because It Was Not the “Maker or Initiator” of Text Message |
Womble Bond Dickinson (US) LLP |
Oct 11 2019 |
U.S. Immigration and the Growing Marijuana Industry |
Jackson Lewis P.C. |
Oct 11 2019 |
Overlapping Provisions in Major Healthcare Bills 2019 |
McDermott Will & Schulte LLP |
Oct 11 2019 |
BRAG Biobased Products Blog: October 11, 2019 |
Bergeson & Campbell, P.C. |
Oct 11 2019 |
OSI v. Apotex – Christmas in October! |
Schwegman, Lundberg & Woessner, P.A. |
Oct 11 2019 |
Do You Want Fries With That? |
Mintz |
Oct 11 2019 |
Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements |
Keller and Heckman LLP |